Italy in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

Product Code GMD08320
Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 151
ISBN Number not applicable
Change currency
PDF £1,580.00 €1,903 $2,498 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Italy in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to the Italy In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Italy

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Italy.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in Italy.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 In Vitro Diagnostics
    • 3.2 Clinical Chemistry Test Reagents
      • 3.2.1 Laboratory Reagents
      • 3.2.2 Clinical Chemistry Calibrators and Controls
      • 3.2.3 Clinical Chemistry Rapid Tests
    • 3.3 Immunochemistry Test Reagents
      • 3.3.1 Disease Specific Markers
        • 3.3.1.1 Tumor Markers
        • 3.3.1.2 Cardiac Markers
      • 3.3.2 Disease Specific Test Reagents
        • 3.3.2.1 Auto-Immune Disease
        • 3.3.2.2 Rheumatoid Disease
        • 3.3.2.3 Anemia/ Vitamins
        • 3.3.2.4 Allergy
      • 3.3.3 Drug Related Testing Reagents
        • 3.3.3.1 Therapeutic Drugs
        • 3.3.3.2 Drug of Abuse and Toxicology
      • 3.3.4 Hormone Related Testing Reagents
        • 3.3.4.1 Specific Proteins
        • 3.3.4.2 Fertility and Pregnancy
        • 3.3.4.3 Individual/Specified hormones
        • 3.3.4.4 Specific Organ Function
      • 3.3.5 Immunochemistry Calibrators and Controls
      • 3.3.6 Immunochemistry Rapid Tests
    • 3.4 Blood Test Reagents
      • 3.4.1 Hematology Test Reagents
        • 3.4.1.1 Hematology
        • 3.4.1.2 Immunohaematology
        • 3.4.1.3 Hematology Calibrators and Controls
        • 3.4.1.4 Immunohaematology Controls
      • 3.4.2 Hemostasis Test Reagents
        • 3.4.2.1 Hemostasis
        • 3.4.2.2 Hemostasis Calibrators and Controls
        • 3.4.2.3 Hemostasis Rapid Tests
      • 3.4.3 Tissue Typing Reagents
      • 3.4.4 Monoclonal Antibodies
      • 3.4.5 Cytokines and Immunomodulators
      • 3.4.6 Histology and Cytology Reagents
    • 3.5 Microbiology Test Reagents
      • 3.5.1 Bacteriology Test Reagents
        • 3.5.1.1 Bacteriology Culture
        • 3.5.1.2 Blood Culture
        • 3.5.1.3 Bacteriology Identification and Susceptibility
      • 3.5.2 Microbiology Calibrators and Controls
      • 3.5.3 Microbiology Rapid Tests
    • 3.6 Infectious Immunology Test Reagents
      • 3.6.1 Bacteriology
      • 3.6.2 Virology
        • 3.6.2.1 Hepatitis Viruses
        • 3.6.2.2 Retroviruses
      • 3.6.3 Parasitology
      • 3.6.4 Infectious Immunology Calibrators and Controls
      • 3.6.5 Infectious Immunology Rapid Tests
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Sector Review
    • 4.2 Healthcare Expenditure
    • 4.3 Healthcare Infrastructure
    • 4.4 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification of Medical Devices
      • 5.1.2 Conformity Assessment Process
        • 5.1.2.1 Class I devices
        • 5.1.2.2 Class IIa devices
        • 5.1.2.3 Class IIb devices
        • 5.1.2.4 Class III devices
    • 5.2 Classificazione Nazionale Dispositivi (CND) - New Medical Device Classification
    • 5.3 Post Market Surveillance
  • 6 Pricing and Reimbursement
    • 6.1 Market Pricing
    • 6.2 Government Policies for Reimbursement
  • 7 Distribution Structure
  • 8 In Vitro Diagnostics In Italy
    • 8.1 In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
    • 8.3 In Vitro Diagnostics, Italy, Company Share (2006-2007)
  • 9 Blood Test Reagents In Italy
    • 9.1 Blood Test Reagents Overall Revenue (2000-2015)
      • 9.1.1 Haematology Test Reagents Revenue (2000-2015)
      • 9.1.2 Hemostasis Test Reagents Revenue (2000-2015)
    • 9.2 Blood Test Reagents Distribution Share (2007-2008)
    • 9.3 Blood Test Reagents, Italy, Company Share (2006-2007)
  • 10 Clinical Chemistry Test Reagents In Italy
    • 10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2015)
    • 10.2 Clinical Chemistry Test Reagents Distribution Share (2007-2008)
    • 10.3 Clinical Chemistry Test Reagents, Italy, Company Share (2006-2007)
  • 11 Genetic Test Reagents In Italy
    • 11.1 Genetic Test Reagents Overall Revenue (2000-2015)
    • 11.2 Genetic Test Reagents Distribution Share (2007-2008)
    • 11.3 Genetic Test Reagents, Italy, Company Share (2006-2007)
  • 12 Immunochemistry Test Reagents In Italy
    • 12.1 Immunochemistry Test Reagents Overall Revenue (2000-2015)
      • 12.1.1 Disease Specific Markers Revenue (2000-2015)
      • 12.1.2 Disease Specific Test Reagents Revenue (2000-2015)
      • 12.1.3 Drug Related Testing Reagents Revenue (2000-2015)
      • 12.1.4 Hormone Related Testing Reagents Revenue (2000-2015)
    • 12.2 Immunochemistry Test Reagents Distribution Share (2007-2008)
    • 12.3 Immunochemistry Test Reagents, Italy, Company Share (2006-2007)
  • 13 Infectious Immunology Test Reagents In Italy
    • 13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2015)
      • 13.1.1 Virology Revenue (2000-2015)
    • 13.2 Infectious Immunology Test Reagents Distribution Share (2007-2008)
    • 13.3 Infectious Immunology Test Reagents, Italy, Company Share (2006-2007)
  • 14 Instruments In Italy
    • 14.1 Instruments Overall Revenue (2000-2015)
    • 14.2 Instruments Distribution Share (2007-2008)
  • 15 Microbiology Test Reagents In Italy
    • 15.1 Microbiology Test Reagents Overall Revenue (2000-2015)
      • 15.1.1 Bacteriology Test Reagents Revenue (2000-2015)
    • 15.2 Microbiology Test Reagents Distribution Share (2007-2008)
    • 15.3 Microbiology Test Reagents, Italy, Company Share (2006-2007)
  • 16 Self Testing In Italy
    • 16.1 Self Testing Overall Revenue (2000-2015)
    • 16.2 Self Testing Distribution Share (2007-2008)
    • 16.3 Self Testing, Italy, Company Share (2006-2007)
  • 17 Overview of Key Companies in Italy In Vitro Diagnostics Market
    • 17.1 F. Hoffmann-La Roche Ltd. Company Profile
      • 17.1.1 Company Overview
      • 17.1.2 Value Chain Analysis
        • 17.1.2.1 Manufacturing
        • 17.1.2.2 Product Development
    • 17.2 Abbott Laboratories Company Profile
      • 17.2.1 Company Overview
      • 17.2.2 Value Chain Analysis
        • 17.2.2.1 Manufacturing
        • 17.2.2.2 Product Development
        • 17.2.2.3 Sales and Marketing
    • 17.3 Beckman Coulter, Inc. Company Profile
      • 17.3.1 Company Overview
      • 17.3.2 Value Chain Analysis
        • 17.3.2.1 Manufacturing
        • 17.3.2.2 Product Development
        • 17.3.2.3 Sales and Marketing
      • 17.3.3 Beckman Coulter, Inc. Pipeline Products
        • 17.3.3.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type
        • 17.3.3.2 Beckman Coulter, Inc. Pipeline Products By Development Stage
        • 17.3.3.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area
        • 17.3.3.4 Beckman Coulter, Inc. Pipeline Products By News Summary
    • 17.4 bioMerieux S.A. Company Profile
      • 17.4.1 Company Overview
      • 17.4.2 Value Chain Analysis
        • 17.4.2.1 Manufacturing
        • 17.4.2.2 Product Development
        • 17.4.2.3 Sales and Marketing
    • 17.5 Dade Behring Holdings, Inc. Company Profile
      • 17.5.1 Company Overview
    • 17.6 Ortho-Clinical Diagnostics Inc. Company Profile
      • 17.6.1 Company Overview
      • 17.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
        • 17.6.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By Equipment Type
        • 17.6.2.2 Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
        • 17.6.2.3 Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
        • 17.6.2.4 Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
    • 17.7 OLYMPUS CORPORATION Company Profile
      • 17.7.1 Company Overview
      • 17.7.2 Value Chain Analysis
        • 17.7.2.1 Manufacturing
        • 17.7.2.2 Product Development
        • 17.7.2.3 Sales and Marketing
      • 17.7.3 Olympus Medical Systems Corp. Pipeline Products
        • 17.7.3.1 Olympus Medical Systems Corp. Pipeline Products by Equipment Type
        • 17.7.3.2 Olympus Medical Systems Corp. Pipeline Products by Development Stage
        • 17.7.3.3 Olympus Medical Systems Corp. Pipeline Products by Therapy Area
        • 17.7.3.4 Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
        • 17.7.3.5 Olympus Medical Systems Corp. Pipeline Products by News Summary
    • 17.8 Gen-Probe Incorporated Company Profile
      • 17.8.1 Company Overview
      • 17.8.2 Value Chain Analysis
        • 17.8.2.1 Manufacturing
        • 17.8.2.2 Product Development
        • 17.8.2.3 Sales and Marketing
      • 17.8.3 Gen-Probe Incorporated Pipeline Products
        • 17.8.3.1 Gen-Probe Incorporated Pipeline Products By Equipment Type
        • 17.8.3.2 Gen-Probe Incorporated Pipeline Products By Development Stage
        • 17.8.3.3 Gen-Probe Incorporated Pipeline Products By Therapy Area
        • 17.8.3.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials
        • 17.8.3.5 Gen-Probe Incorporated Pipeline Products By News Summary
    • 17.9 Becton, Dickinson and Company Profile
      • 17.9.1 Company Overview
      • 17.9.2 Value Chain Analysis
        • 17.9.2.1 Manufacturing
        • 17.9.2.2 Product Development
        • 17.9.2.3 Sales and Marketing
    • 17.10 Digene Corporation Company Profile
      • 17.10.1 Company Overview
    • 17.11 Siemens Healthcare Company Profile
      • 17.11.1 Company Overview
      • 17.11.2 Value Chain Analysis
        • 17.11.2.1 Manufacturing
        • 17.11.2.2 Product Development
        • 17.11.2.3 Sales and Marketing
    • 17.12 ACZON S.p.A. Company Profile
      • 17.12.1 Company Overview
    • 17.13 Chromogenix Instrumentation Laboratory S.p.A. Company Profile
      • 17.13.1 Company Overview
    • 17.14 DiaSorin S.p.A Company Profile
      • 17.14.1 Company Overview
    • 17.15 Health Robotics S.R.L. Company Profile
      • 17.15.1 Company Overview
    • 17.16 MeDia IVD S.r.l. Company Profile
      • 17.16.1 Company Overview
    • 17.17 Radim S.p.A. Company Profile
      • 17.17.1 Company Overview
  • 18 Financial Deals Landscape
    • 18.1 Partnerships
      • 18.1.1 NorDiag Enters Into an Agreement with Diatech
      • 18.1.2 Biotools, B & M Labs Enters Into an Agreement with Diapro
      • 18.1.3 Nanogen Enters Into an Agreement with A. Menarini Diagnostics
  • 19 Appendix
    • 19.1 Global Markets Direct Research Methodology
    • 19.2 Coverage
    • 19.3 Secondary Research
    • 19.4 Primary Research
    • 19.5 Models
    • 19.6 Forecasts
    • 19.7 Expert Panel Validation
    • 19.8 Currency Conversion
    • 19.9 Contact Us
    • 19.10 Disclaimer
  • 1 List of Tables
    • Table 1: Number of Doctors by Specialty in Italy, 2003-2007
    • Table 2: Number of Hospital Wards by Specialty in Italy, 2003-2007
    • Table 3: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 4: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
    • Table 5: In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015
    • Table 6: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 7: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 8: In Vitro Diagnostics, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 9: Blood Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 10: Blood Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 11: Haematology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 12: Haematology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 13: Hemostasis Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 14: Hemostasis Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 15: Blood Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 16: Blood Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 17: Clinical Chemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 18: Clinical Chemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 19: Clinical Chemistry Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 20: Clinical Chemistry Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 21: Genetic Test Reagents, Italy, Revenue ($ mn), Historic, 2000-2008
    • Table 22: Genetic Test Reagents, Italy, Revenue ($ mn), Forecast, 2008-2015
    • Table 23: Genetic Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 24: Genetic Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 25: Immunochemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 26: Immunochemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 27: Disease Specific Markers, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 28: Disease Specific Markers, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 29: Disease Specific Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 30: Disease Specific Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 31: Drug Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 32: Drug Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 33: Hormone Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 34: Hormone Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 35: Immunochemistry Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 36: Immunochemistry Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 37: Infectious Immunology Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 38: Infectious Immunology Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 39: Virology, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 40: Virology, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 41: Infectious Immunology Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 42: Infectious Immunology Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 43: Instruments, Italy, Revenue ($ mn), Historic, 2000-2008
    • Table 44: Instruments, Italy, Revenue ($ mn), Forecast, 2008-2015
    • Table 45: Instruments, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 46: Microbiology Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 47: Microbiology Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 48: Bacteriology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 49: Bacteriology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 50: Microbiology Test Reagents, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 51: Microbiology Test Reagents, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 52: Self Testing, Italy, Revenue ($ mn), Historic, 2000-2008
    • Table 53: Self Testing, Italy, Revenue ($ mn), Forecast, 2008-2015
    • Table 54: Self Testing, Italy, Distribution Share by Revenue ($mn), 2007-2008
    • Table 55: Self Testing, Italy, Company Share by Revenue ($ mn), 2006-2007
    • Table 56: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 57: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 58: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 59: Beckman Coulter, Inc. Pipeline Products By News Summary
    • Table 60: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
    • Table 61: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
    • Table 62: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
    • Table 63: Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
    • Table 64: Olympus Medical Systems Corp. Pipeline Products by Equipment Type
    • Table 65: Olympus Medical Systems Corp. Pipeline Products by Development Stage
    • Table 66: Olympus Medical Systems Corp. Pipeline Products by Therapy Area
    • Table 67: Olympus Medical Systems Corp. Pipeline Products by Clinical Trials
    • Table 68: Olympus Medical Systems Corp. Pipeline Products by News Summary
    • Table 69: Gen-Probe Incorporated Pipeline Products by Equipment Type
    • Table 70: Gen-Probe Incorporated Pipeline Products By Development Stage
    • Table 71: Gen-Probe Incorporated Pipeline Products By Therapy Area
    • Table 72: Gen-Probe Incorporated Pipeline Products By Clinical Trials
    • Table 73: Gen-Probe Incorporated Pipeline Products By News Summary
    • Table 74: NorDiag Enters Into An Agreement With Diatech
    • Table 75: Biotools, B & M Labs Enters Into An Agreement With Diapro
    • Table 76: Nanogen Enters Into An Agreement With A. Menarini Diagnostics
    • Table 77: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in Italy, 2000 - 2006
    • Figure 2: Healthcare Financing Framework in Italy, 2007
    • Figure 3: Flowchart for Classification of Non-invasive Devices in Italy, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in Italy, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in Italy, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in Italy, 2007
    • Figure 7: Flowchart for Classification of Invasive Devices in Italy, 2007
    • Figure 8: Flowchart for Classification of Active Devices in Italy, 2007
    • Figure 9: Flowchart for Classification of Active Devices in Italy, 2007
    • Figure 10: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Italy, 2007
    • Figure 11: Conformity Assessment of Class-I Medical Devices in Italy, 2007
    • Figure 12: Conformity Assessment of Class-IIa Medical Devices in Italy, 2007
    • Figure 13: Conformity Assessment of Class-IIb Medical Devices in Italy, 2007
    • Figure 14: Conformity Assessment of Class-III Medical Devices in Italy, 2007
    • Figure 15: In Vitro Diagnostics Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 16: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
    • Figure 17: In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015
    • Figure 18: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 19: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 20: In Vitro Diagnostics, Italy, Company Share (%), 2007
    • Figure 21: Blood Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 22: Blood Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 23: Haematology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 24: Haematology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 25: Hemostasis Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 26: Hemostasis Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 27: Blood Test Reagents, Italy, Company Share (%), 2007
    • Figure 28: Clinical Chemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 29: Clinical Chemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 30: Clinical Chemistry Test Reagents, Italy, Company Share (%), 2007
    • Figure 31: Genetic Test Reagents, Italy, Revenue ($ mn), Historic, 2000-2008
    • Figure 32: Genetic Test Reagents, Italy, Revenue ($ mn), Forecast, 2008-2015
    • Figure 33: Genetic Test Reagents, Italy, Company Share (%), 2007
    • Figure 34: Immunochemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 35: Immunochemistry Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 36: Disease Specific Markers, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 37: Disease Specific Markers, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 38: Disease Specific Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 39: Disease Specific Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 40: Drug Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 41: Drug Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 42: Hormone Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 43: Hormone Related Testing Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 44: Immunochemistry Test Reagents, Italy, Company Share (%), 2007
    • Figure 45: Infectious Immunology Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 46: Infectious Immunology Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 47: Virology, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 48: Virology, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 49: Infectious Immunology Test Reagents, Italy, Company Share (%), 2007
    • Figure 50: Instruments, Italy, Revenue ($ mn), Historic, 2000-2008
    • Figure 51: Instruments, Italy, Revenue ($ mn), Forecast, 2008-2015
    • Figure 52: Microbiology Test Reagents, Italy, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 53: Microbiology Test Reagents, Italy, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 54: Bacteriology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 55: Bacteriology Test Reagents, Italy, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 56: Microbiology Test Reagents, Italy, Company Share (%), 2007
    • Figure 57: Self Testing, Italy, Revenue ($ mn), Historic, 2000-2008
    • Figure 58: Self Testing, Italy, Revenue ($ mn), Forecast, 2008-2015
    • Figure 59: Self Testing, Italy, Company Share (%), 2007
    • Figure 60: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 61: Abbott Laboratories Value Chain Analysis
    • Figure 62: Beckman Coulter, Inc. Value Chain Analysis
    • Figure 63: Biomerieux Sa Value Chain Analysis
    • Figure 64: Olympus Medical Systems Corp. Value Chain Analysis
    • Figure 65: Gen-Probe Incorporated Value Chain Analysis
    • Figure 66: Becton, Dickinson and Company Value Chain Analysis
    • Figure 67: Siemens Medical Solutions Value Chain Analysis
    • Figure 68: Global Markets Direct Methodology